Joint Symposium ESMO-EORTC-EACR: What has melanoma taught us about targeted therapies and immunotherapy?
Patient advocacy initiatives
Date
09 Oct 2016Session
Joint Symposium ESMO-EORTC-EACR: What has melanoma taught us about targeted therapies and immunotherapy?Presenters
Bettina RyllAuthors
B. RyllAuthor affiliations
- Melanoma Patient Network Europe, Uppsala/SE
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Where next in targeted therapies and melanoma?
Presenter: Richard Marais
Session: Joint Symposium ESMO-EORTC-EACR: What has melanoma taught us about targeted therapies and immunotherapy?
Resources:
Slides
Where next in immunotherapy and melanoma?
Presenter: Paolo Ascierto
Session: Joint Symposium ESMO-EORTC-EACR: What has melanoma taught us about targeted therapies and immunotherapy?
Resources:
Slides
Webcast
Introduction
Presenter: Rolf A. Stahel
Session: Joint Symposium ESMO-EORTC-EACR: What has melanoma taught us about targeted therapies and immunotherapy?
Resources:
Webcast